Oxidative Stress and Cardiac Arrest

This study has been completed.

Sponsor:

Information provided by:

Institut d'Anesthesiologie des Alpes Maritimes

ClinicalTrials.gov Identifier:

NCT00888966

First received: April 25, 2009

Last updated: June 30, 2011

Last verified: June 2011

History of Changes

Purpose

Cardiac arrest is a major health problem reaching 375000 cases in Europe each year. Only 5 to 31 % survive after an out of hospital cardiac arrest (OHCA). The main complication after OHCA is the anoxic encephalopathy. Recently mild hypothermia has shown a beneficial effect on survival. But the mechanisms underlying these therapy are not clear.

Cardiac arrest is an example of ischemia reperfusion of the entire body. And it is well demonstrated that reperfusion generates an oxidative stress. But it has never been shown in a clinical setting.

The aim of the study is to evaluate oxidative stress after out of hospital cardiac arrest treated with mild hypothermia.

Condition
Heart Arrest


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Evaluation of Oxidative Stress After Out of Hospital Cardiac Arrest Treated With Moderate Hypothermia

Resource links provided by NLM:

MedlinePlus related topics: Cardiac Arrest Health Facilities Hypothermia

U.S. FDA Resources

Further study details as provided by Institut d'Anesthesiologie des Alpes Maritimes:

Primary Outcome Measures:

Oxidative stress markers and antioxidants after out of hospital cardiac arrest [ Time Frame: 4 days ]

Secondary Outcome Measures:

Lactate after out of hospital cardiac arrest [ Time Frame: 4 days ]
Outcome after out of hospital cardiac arrest [ Time Frame: 6 months ]

Biospecimen Retention: Samples Without DNA

Plasma


Estimated Enrollment:	40
Study Start Date:	April 2006
Study Completion Date:	December 2010
Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts
Out of hospital cardiac arrest Out of hospital cardiac patients successfully resuscitated and admitted to ICU

Eligibility


Ages Eligible for Study:	18 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

community sample

Criteria

Inclusion Criteria:

Out of hospital cardiac arrest

Exclusion Criteria:

refractory shock
moribund patient
resuscitation > 60 minutes
hypothermia < 30 degrees

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00888966

Locations


France
CHU de Nice
Nice, France, 06003

Sponsors and Collaborators

Institut d'Anesthesiologie des Alpes Maritimes

Investigators


Study Chair:	Carole Ichai, MD, PhD	CHU de Nice

More Information


Responsible Party:	Orban MD, CHU de Nice
ClinicalTrials.gov Identifier:	NCT00888966 History of Changes
Other Study ID Numbers:	IAAM 2009-2
Study First Received:	April 25, 2009
Last Updated:	June 30, 2011

Keywords provided by Institut d'Anesthesiologie des Alpes Maritimes:


heart arrest oxidative stress lactic acid outcome

Additional relevant MeSH terms:


Heart Arrest Out-of-Hospital Cardiac Arrest Heart Diseases Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 21, 2017

To Top